Effects of diesel organic extracts on chemokine production by peripheral blood mononuclear cells

Journal of Allergy and Clinical Immunology

Volumn 103, Issue 6, 1999, Pages 1115-1124

  Fahy, Olivier ^c   Tsicopoulos, Anne ^a   Hammad, Hamida ^c   Pestel, Joël ^c   Tonnel, André Bernard ^a,b   Wallaert, Benoît ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c NONE

Author keywords

Air pollution; Chemokines; Diesel; Inflammation; PBMC

Indexed keywords

CHEMOKINE; DIESEL FUEL; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYCYCLIC AROMATIC HYDROCARBON; RANTES;

ARTICLE; BRONCHITIS; BRONCHUS HYPERREACTIVITY; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; EOSINOPHIL; EXHAUST GAS; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; MONONUCLEAR CELL; NEUTROPHIL CHEMOTAXIS; POLLUTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032864567     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70187-9     Document Type: Article

References (36)

1. 1. Peterson B, Saxon A. Global increases in allergic respiratory disease: the possible role of diesel exhaust particles. Ann Allergy Asthma Immunol 1996;77:263-70.
2. 2. La pollution atmosphérique d'origine automobile et la santé publique. Société française de santé publique. Collection Santé et société, No. 4, 1996.
3. 3. Morgan WKC, Reger RB, Tucker DM. Health effects of diesel emissions. Ann Occup Hyg 1997;41:643-58.
4. 4. Robinson DS, Hamid Q. Ying S, Tsicopoulos A, Barkans J, Bentley AM, et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
5. 5. Del Prete G, Maggi E, Parronchi P, Chretien I, Tiri A, Macchia D, et al. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988;140:4193-8.
6. 6. Shi H, Qin S, Huang G, Chen Y, Xiao C, Xu H, et al. Infiltration of eosinophils into the asthmatic airways caused by interleukin 5. Am J Respir Cell Mol Biol 1997;16:220-4.
7. 7. Takenaka H, Zhang K, Diaz-Sanchez D, Tsien A, Saxon A. Enhanced human IgE production results from exposure to the aromatic hydrocarbons from diesel exhaust: direct effects on B-cell IgE production. J Allergy Clin Immunol 1995;95:103-15.
8. 8. Tsien A, Diaz-Sanchez D, Ma J, Saxon A. The organic component of diesel exhaust particles and phenanthrene, a major polyaromatic hydrocarbon constituent, enhances IgE production by IgE-secreting EBV-transformed human B cells in vitro. Toxicol Appl Pharmacol 1997;142:256-63.
9. 9. Takafuji S, Suzuki S, Koizumi K, Tadokoro K, Miyamoto T, Ikemori R, et al. Diesel-exhaust particulates inoculated by the intranasal route have an adjuvant activity for IgE production in mice. J Allergy Clin Immunol 1987;79:639-45.
10. 10. Diaz-Sanchez D., Dotson AR, Takenaka H, Saxon A. Diesel exhaust particles induce local IgE production in vivo and alter the pattern of IgE messenger RNA isoforms. J Clin Invest 1994;94:1417-25.
11. 11. Diaz-Sanchez D, Tsien A, Casillas A, Dotson AR, Saxon A. Enhanced nasal cytokine production in human beings after in vivo challenge with diesel exhaust particles. J Allergy Clin Immunol 1996;98:114-23.
12. 12. Kanemitsu H, Nagasawa S, Sagai M, Mori Y. Complement activation by diesel exhaust particles. Biol Pharm Bull 1998;21:129-32.
13. 13. Saneyoshi K, Nohara O, Imai T, Shiraishi F, Moriyama H, Fujimaki H. IL-4 and IL-6 production of bone marrow-derived mast cells is enhanced by treatment with environmental pollutants. Int Arch Allergy Immunol 1997;114:237-45.
14. 14. Terada N, Maesako K, Hiruma K, Hamano N, Houki G, Konno A, et al. Diesel exhaust particulates enhance eosinophil adhesion to nasal epithelial cells and cause degranulation. Int Arch Allergy Immunol 1997;114:167-74.
15. 15. Bayram H, Devalia JL, Sapsford RJ, Ohtoshi T, Miyabara Y, Sagai M, et al. The effect of diesel exhaust particles on cell function and release of inflammatory mediators from human bronchial epithelial cells in vitro. Am J Respir Cell Mol Biol 1998;18:441-8.
16. 16. Teran LM, Davies DE. The chemokines: their potential role in allergic inflammation. Clin Exp Allergy 1996;26:1005-19.
17. 17. Bischoff SC, Krieger M, Brunner T, Dahinden CA. Monocyte chemotactic protein 1 is a potent activator of human basophils. J Exp Med 1992;175:1271.
18. 18. Alam R, Stafford S, Forsythe P, Harrison R, Faubion D, Lett BM, et al. RANTES is a chemotactic and activating factor for human eosinophils. J Immunol 1993;150:3442-7.
19. 19. Kimata H, Yoshida A, Ishioka C, Fujimoto M, Lindley I, Furusho K. RANTES and macrophage inflammatory protein 1 alpha selectively enhance immunoglobulin (IgE) and IgG4 production by human B cells. J Exp Med 1996;183:2397-402.
20. 20. Akoum H, Duez C, Vorng H, Fahy O, Wallaert B, Tonnel AB, et al. Early modifications of chemokine production and mRNA expression during rush venom immunotherapy. Cytokine 1998;10:706-12.
21. 21. Boyüm A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Invest 1968;21:77-83.
22. 22. Molet S, Gosset P, Vanhee D, Tillie-Leblond I, Wallaert B, Capron M, et al. Modulation of cell adhesion molecules on human endothelial cells by eosinophil-derived mediators. J Leukoc Biol 1998;63:351-8.
23. 23. Eierman DF, Johnson CE, Haskill JS. Human monocyte inflammatory mediator gene expression is selectively regulated by adherence substrates. J Immunol 1989;142:1970-6.
24. 24. Klinger MH, Wilhelm D, Bubel S, Sticherling M, Schroder JM, Kuhnel W. Immunocytochemical localization of the chemokines RANTES and MIP-1 alpha within human platelets and their release during storage. Int Arch Allergy Immunol 1995;107:541-6.
25. 25. Kameyoshi Y, Dorschner A, Mallet AI, Christophers E, Schroder JM. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 1992;176:587-92.
26. 26. Garcia Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med 1996;2:449-56.
27. 27. Grant GFM. Dioxin-receptor ligands in urban air and vehicle exhaust. Environ Health Perspect 1994;102:111-6.
28. 28. Sogawa K, Fujii-Kuriyama Y. Ah receptor, a novel ligand-activated transcription factor. J Biochem 1997;122:1075-9.
29. 29. Rowlands JC, Gustafsson J. Aryl hydrocarbon receptor-mediated signal transduction. Crit Rev Toxicol 1997;27:109-34.
30. 30. Sutter TR, Greenlee WF. Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1. Science 1991;254:415-8.
31. 31. Kharat I, Saatcioglu F. Antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin are mediated by direct transcriptional interference with the liganded estrogen receptor. Cross-talk between aryl hydrocarbon-and estrogen-mediated signaling. J Biol Chem 1996;271:10533-7.
32. 32. Gebremichael A, Tullis A, Denison MS, Cheek JM, Pinkerton KE. Ah-Receptor-dependent modulation of gene expression by aged and diluted sidestream cigarette smoke. Toxicol Appl Pharmacol 1996;141:76-83.
33. 33. Reiners JJ Jr, Lee JY, Clift RE, Dudley DT, Myrand SP. PD98059 is an equipotent antagonist of the aryl hydrocarbon receptor and inhibitor of mitogen-activated protein kinase kinase. Mol Pharmacol 1998;53:438-45.
34. 34. Chan WK, Chu R, Jain S, Reddy JK, Bradfield CA. Baculovirus expression of the Ah receptor and Ah receptor nuclear translocater. J Biol Chem 1994;269:26464-71.
35. 35. Takano H, Yoshikawa T, Ichinose T, Miyabara Y, Imaoka K, Sagai M. Diesel exhaust particles enhance antigen-induced airway inflammation and local cytokine expression in mice. Am J Respir Crit Care Med 1997;156:36-42.
36. 36. Weller PF. Eosinophils: structure and functions. Curr Opin Immunol 1994;6:85-90.